Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
Per Ljungman, Małgorzata Mikulska, Rafael de la Cámara, Grzegorz Basak, Christian Chabannon, Selim Corbacioglu, Rafael F. Duarte, Harry Dolstra, Arjan C. Lankester, Mohamad Mohty, Silvia Montoto, John Murray, Régis Peffault de Latour, John A. Snowden, Ibrahim Yakoub‐Agha, Bregje Verhoeven, Nicolaus Kröger, Jan Styczyński, for the European Society for Blood and Marrow Transplantation
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Topics & Concepts
Hematopoietic cellMedicineHematopoietic stem cell transplantationCoronavirus disease 2019 (COVID-19)OncologyIntensive care medicineTransplantationHaematopoiesis2019-20 coronavirus outbreakMEDLINEInternal medicineStem cellVirologyDiseaseBiologyPolitical scienceGeneticsLawInfectious disease (medical specialty)OutbreakCAR-T cell therapy research